Intakes of coffee, tea, milk, soda and juice and renal cell cancer in a pooled analysis of 13 prospective studies. by Lee, J.E. et al.
  
 
Intakes of coffee, tea, milk, soda and juice and renal
cell cancer in a pooled analysis of 13 prospective
studies.
Citation for published version (APA):
Lee, J. E., Hunter, D. J., Spiegelman, D., Adami, H. O., Bernstein, L., van den Brandt, P. A., ... Smith
Warner, S. A. (2007). Intakes of coffee, tea, milk, soda and juice and renal cell cancer in a pooled analysis
of 13 prospective studies. International Journal of Cancer, 121(10), 2246-2253.
https://doi.org/10.1002/ijc.22909
Document status and date:
Published: 01/01/2007
DOI:
10.1002/ijc.22909
Document Version:
Publisher's PDF, also known as Version of record
Please check the document version of this publication:
• A submitted manuscript is the version of the article upon submission and before peer-review. There can
be important differences between the submitted version and the official published version of record.
People interested in the research are advised to contact the author for the final version of the publication,
or visit the DOI to the publisher's website.
• The final author version and the galley proof are versions of the publication after peer review.
• The final published version features the final layout of the paper including the volume, issue and page
numbers.
Link to publication
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these
rights.
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
• You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal.
If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license above,
please follow below link for the End User Agreement:
www.umlib.nl/taverne-license
Take down policy
If you believe that this document breaches copyright please contact us at:
repository@maastrichtuniversity.nl
providing details and we will investigate your claim.
Download date: 04 Dec. 2019
Intakes of coffee, tea, milk, soda and juice and renal cell cancer in a pooled
analysis of 13 prospective studies
Jung Eun Lee1*, David J. Hunter1,2,3, Donna Spiegelman3,4, Hans-Olov Adami3,5, Leslie Bernstein6,
Piet A. van den Brandt7, Julie E. Buring3,8, Eunyoung Cho1, Dallas English9, Aaron R. Folsom10,
Jo L. Freudenheim11, Graham G. Gile9, Edward Giovannucci1,2,3, Pamela L. Horn-Ross12, Michael Leitzmann13,
James R. Marshall14, Satu M€annist€o15, Marjorie L. McCullough16, Anthony B. Miller17, Alexander S. Parker18,
Pirjo Pietinen15, Carmen Rodriguez16, Thomas E. Rohan19, Arthur Schatzkin13, Leo J. Schouten7,
Walter C. Willett1,2,3, Alicja Wolk20, Shumin M. Zhang3,8 and Stephanie A. Smith-Warner2,3
1Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School,
Boston, MA
2Department of Nutrition, Harvard School of Public Health, Boston, MA
3Department of Epidemiology, Harvard School of Public Health, Boston, MA
4Department of Biostatistics, Harvard School of Public Health, Boston, MA
5Department of Medical Epidemiology and Biostatistics, National Institute of Environmental Medicine,
Karolinska Institutet, Stockholm, Sweden
6Department of Preventive Medicine and USC/Norris Comprehensive Cancer Center, University of Southern
California, Los Angeles, CA
7Department of Epidemiology, NUTRIM, Maastricht University, Maastricht, The Netherlands
8Division of Preventive Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA
9Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Australia
10Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN
11Department of Social and Preventive Medicine, University at Buffalo, State University of New York, Buffalo, NY
12Northern California Cancer Center, Fremont, CA
13Division of Cancer Epidemiology and Genetics, Department of Health and Health Services, National Cancer Institute,
National Institute of Health, Bethesda, MD
14Roswell Park Cancer Institute, Buffalo, NY
15Department of Health Promotion and Chronic Disease Prevention, National Public Health Institute, Helsinki, Finland
16Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA
17Department of Public Health Sciences, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
18Department of Urology, Mayo Clinic College of Medicine, Jacksonville, FL
19Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY
20Division of Nutritional Epidemiology, National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
Speciﬁc beverage intake may be associated with the risk of renal
cell cancer through a diluting effect of carcinogens, alterations of
hormone levels, or other changes in the renal tubular environ-
ment, but few prospective studies have examined these associa-
tions. We evaluated the associations between coffee, tea, milk,
soda and fruit and vegetable juice intakes and renal cell cancer
risk in a pooled analysis of 13 prospective studies (530,469 women
and 244,483 men). Participants completed a validated food-
frequency questionnaire at baseline. Using the primary data, the
study-speciﬁc relative risks (RRs) were calculated and then pooled
using a random effects model. A total of 1,478 incident renal cell
cancer cases were identiﬁed during a follow-up of 7–20 years
across studies. Coffee consumption was associated with a modestly
lower risk of renal cell cancer (pooled multivariate RR for 3 or
more 8 oz (237 ml) cups/day versus less than one 8 oz (237 ml)
cup/day 5 0.84; 95% CI 5 0.67–1.05; p value, test for trend 5
0.22). Tea consumption was also inversely associated with renal
cell cancer risk (pooled multivariate RR for 1 or more 8 oz (237
ml) cups/day versus nondrinkers 5 0.85; 95% CI 5 0.71–1.02;
p value, test for trend 5 0.04). No clear associations were observed
for milk, soda or juice. Our ﬁndings provide strong evidence that
neither coffee nor tea consumption increases renal cell cancer
risk. Instead, greater consumption of coffee and tea may be associ-
ated with a lower risk of renal cell cancer.
' 2007 Wiley-Liss, Inc.
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Renal cell cancer incidence rates have been increasing steadily
over the past 3 decades.1 However, the etiology of renal cell cancer
remains unclear. Given that the main functions of the kidneys are
to regulate water and inorganic-ion balance, and to excrete waste
products and foreign chemicals,2 the risk of renal cell cancer may
be affected by the quantity and type of beverages consumed. More
speciﬁcally, beverages containing caffeine and/or antioxidants
may reduce renal cell cancer risk because caffeine has a diuretic
effect by blocking anti-diuretic hormone,2 and antioxidants allevi-
ate oxidative damage to DNA, proteins and other molecules.3
Moreover, coffee and tea intake may reduce the risk of renal cell
cancer by improving insulin sensitivity.4,5 Beverages high in pro-
tein, such as milk, may increase the risk of renal cell cancer
because high protein intakes may cause renal hypertrophy or renal
damage.6
Inconsistent associations with risk of renal cell cancer have
been observed in several case-control studies for intakes of coffee
and tea,7–18 soda,7–9,11,16,18 juice19 and milk.9–11,17,19–21 However,
very few prospective studies22–25 have examined these relation-
ships because many prospective studies have a relatively small
number of incident renal cell cancer cases. We therefore examined
the associations between intakes of coffee, tea, milk, soda and
juice and risk of incident renal cell cancer in a pooled analysis of
13 prospective studies including 1,478 renal cell cancer cases. We
previously reported a modest inverse association between alcohol
intake and renal cell cancer risk.26
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Material and methods
Study population
The Pooling Project of Prospective Studies of Diet and Cancer
(referred to as the Pooling Project) has been described else-
where.27 For the renal cell cancer analyses, each included study
met the following prespeciﬁed criteria: at least one publication on
a diet and cancer association, identiﬁcation of at least 25 incident
renal cell cancer cases, assessment of long-term dietary intake,
and validation of the dietary assessment method or a closely
related instrument. Studies including both men and women were
treated as 2 separate cohorts (1 of men and 1 of women) and the
inclusion criteria were applied to each gender-speciﬁc cohort.
Overall, the renal cell cancer analyses included 530,469 women
and 244,483 men from 13 prospective studies. The Canadian
National Breast Screening Study and the Netherlands Cohort
Study were each analyzed as case-cohort studies.28 In the Pooling
Project, we have divided the person-time of the Nurses’ Health
Study into 2 segments corresponding to the 1980–1986 follow-up
period (part a) and follow-up beginning in 1986 (part b) to take
advantage of the increased comprehensiveness of the food-fre-
quency questionnaire (FFQ) completed in 1986 (n 5 131 food
items) compared to the FFQ completed in 1980 (n 5 61 food
items). In the renal cell cancer analyses, we only used data from
the Nurses’ Health Study (part b) because fewer than 25 cases
were identiﬁed between 1980 and 1986.
Case ascertainment
Cases were ascertained by follow-up questionnaires and subse-
quent review of medical records,22,29 linkage to cancer regis-
tries,23,24,30–34 or both.35–37 Some studies also used linkage to
mortality registries to identify outcomes.22–24,29,30,33–37 We
deﬁned renal cell cancer cases as those with histologically con-
ﬁrmed renal cell cancer (ICD-O-2 code 5 C64.9; ICD-9 5 189.0)
using histological codes based on the International Classiﬁcation
of Diseases for Oncology38,39 or the morphological classiﬁcation
provided by the study investigators. The majority (62%) of cases
were classiﬁed as renal cell carcinoma, NOS (morphology code 5
8312) and clear cell carcinoma was the second most frequent
(20%) histologic subgroup. The proportion of renal cell carci-
noma, NOS in our database is higher than that reported in surgical
series which have reported clear cell carcinoma as the most com-
mon type of renal cell cancer.40 This may be due to, in part, the
large number of renal cell cancer cases in our data that were ascer-
tained before a 1997 workshop on the diagnosis and prognosis of
renal cell cancer held by the World Health Organization,40 which
prompted more widespread use of the currently used classiﬁcation
system. We have combined all histologically conﬁrmed renal cell
cancers together in our analyses due to the insufﬁcient number of
cases for histology-speciﬁc analyses.
Assessment of beverage and other dietary intake
Each study assessed baseline consumption of several beverages
using a validated FFQ or diet history. Each study provided food
and beverage intake data as either the number of servings con-
sumed per day or grams consumed per day. For those studies that
quantiﬁed intake in servings per day, the intake of each beverage
was converted to grams per day based on the frequency reported
and study-speciﬁc serving sizes. Intake of each beverage group
was calculated by summing the intake of the related individual
beverages listed on each study’s FFQ. We excluded from the anal-
yses of coffee and tea 2 studies (Breast Cancer Detection Demon-
stration Project Follow-Up Study and Cancer Prevention Study II
Nutrition Cohort) that did not inquire about coffee and tea con-
sumption at baseline and 1 study (California Teachers Study) that
asked a combined question on coffee and tea intake. We were not
able to separate caffeinated, decaffeinated and herbal tea because
most studies did not assess intakes of speciﬁc types of tea. The
FFQ used in the Melbourne Collaborative Cohort Study41 did not
assess overall milk consumption and therefore, this study was
excluded for the milk analyses. Each study also provided intake
data for several nutrients.
Although each study in this analysis conducted a validation
study for their diet assessment method,27 the results for beverage
consumption were reported in only a few of the validation studies.
In these studies, the correlation coefﬁcients comparing beverage
intake from the FFQs to diet records generally exceeded 0.6 for
coffee, tea, milk, soda and juice,42–44 or nonalcoholic beverages.45
Assessment of nondietary factors
Information on nondietary factors was collected at baseline in
each study using self-administered questionnaires. Age, height
and weight were asked in all studies; body mass index (BMI,
weight (kg)/height (m2)) was calculated using height and weight
at the start of the follow-up period. All the cohort studies includ-
ing women assessed parity and age at ﬁrst birth. Three studies did
not measure history of hypertension, and 1 study had a large pro-
portion of missing data on history of hypertension. One study did
not measure smoking habits.
Statistical analysis
After applying the study-speciﬁc exclusion criteria, we further
excluded participants if they consumed an unreasonable energy
intake (63 SDs from the study-speciﬁc loge-transformed mean
energy intake), had a history of cancer except for nonmelanoma
skin cancer at baseline, or had missing data on speciﬁc beverage
intake (if applicable). Each study was analyzed using the Cox pro-
portional hazards model.46 Age at baseline (in days) and the year
that the baseline questionnaire was returned were used as stratiﬁ-
cation variables, thereby creating a time metric, which simultane-
ously accounted for age, calendar time and time since entry into
the study. Person-years of follow-up time were calculated from
the date of the baseline questionnaire until the date of renal cell
cancer diagnosis, death, loss to follow-up, if applicable, or end of
follow-up, whichever came ﬁrst.
We categorized the intake of each beverage using uniform cut-
points across studies. We deﬁned 1 serving as 237 g (8 oz) for
coffee and tea, 245 g (8 oz) for milk, 186 g (6 oz) for juice and
355 g (12 oz) for soda. If there were no cases in the highest intake
category in a study, the relative risk (RR) for the highest category
could not be estimated in that study and the noncases in the high-
est category were included in the second highest category. To cal-
culate the p-value for the test for trend, participants were assigned
the median value of their intake category and this variable was
treated as a continuous term in the model. In the multivariate anal-
yses, we further adjusted for BMI (continuous), history of hyper-
tension (yes, no), pack-years of smoking (continuous), energy
intake (continuous), fruit and vegetable consumption (tertiles),
alcohol intake (continuous), and, among women, parity and age at
ﬁrst birth (1 or 2 children and age at ﬁrst birth <25 years old, 1 or
2 children and age at ﬁrst birth 25 years old or nulliparous, 3
children and age at ﬁrst birth <25 years old, and 3 children and
age at ﬁrst birth 25 years old). Among studies that measured
covariates included in the analyses, mean proportion of missing
data across studies ranged from 0.2 to 5% for BMI, history of
hypertension, pack-years of smoking, and among women, parity
and age at ﬁrst birth. Alcohol intake, and fruit and vegetable
intake generally did not have missing responses. For each meas-
ured covariate in a study, an indicator variable was used for miss-
ing responses, if needed.
After calculating study- and gender-speciﬁc RRs for each cate-
gory, we combined the loge RRs using a random effects
model.47,48 The individual study estimates were weighted by the
inverse of their variance. We tested for heterogeneity between
studies using the Q statistic.49,50 Two-sided 95% conﬁdence inter-
vals (CIs) were calculated.
To assess whether the associations between intakes of coffee
and tea and risk of renal cell cancer were linear, we examined non-
parametric regression curves using restricted cubic splines51,52. To
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test for nonlinearity, the model ﬁt including the linear and cubic
spline terms selected by a stepwise regression procedure was com-
pared to the model ﬁt with only the linear term using the likeli-
hood ratio test, and by visual inspection of the restricted cubic
spline graphs. For these analyses, all studies were combined into a
single dataset, and then stratiﬁed by age, the year that the ques-
tionnaire was returned, and study, and were adjusted for other
covariates in the model. For analyses of each beverage, individu-
als reporting extremely high intake (top 1% of participants in the
aggregated dataset) of that beverage were excluded from the analy-
sis to reduce the inﬂuence of extreme values.
We examined whether the associations between each beverage
and renal cell cancer varied by gender, median age at diagnosis
(<68, 68 years), smoking status (never, past, current smoker),
and parity (nulliparous or 1 child, 2 children, 3 children) using a
mixed effects meta-regression model.53 For evaluation of whether
BMI (<25, 25 kg/m2), history of hypertension (no, yes), alcohol
intake (nondrinkers, drinkers), hormone replacement therapy (ever,
never) and oral contraceptive use (user, nonuser) modiﬁed the asso-
ciation for each beverage, we used a Wald test of the pooled cross-
product term of beverage intake as a continuous variable with the
speciﬁc modiﬁer variable modeled as a dichotomous variable.
Results
During maximum follow-up periods of 7–20 years across studies,
1,478 incident renal cell cancer cases (709 women and 769
men) were diagnosed among 530,469 women and 244,483 men
(Table I).
Consumption of each beverage varied across studies. There
were 3- to 5-fold differences in the median intakes of coffee, tea
and milk across studies. Coffee was consumed more frequently
and in higher quantities than tea. There was more than a 10-fold
variation in median soda and juice intake across studies.
Coffee consumption was associated, but not signiﬁcantly, with
a lower risk of renal cell cancer overall (Table II). Inverse associa-
tion was observed in women, although the difference in the results
between women and men was not statistically signiﬁcant (p value,
test for between-studies heterogeneity due to gender for the
 three 8 oz servings/day category 5 0.13). When we alterna-
tively adjusted for smoking habits using categories of never smok-
ers, 2 categories of years smoked among past smokers (<30 years,
30 years), and 3 levels of amount smoked among current smok-
ers (<15 cigarettes/day, 15 to <25 cigarettes/day, 25 cigarettes/
day), the results (data not shown) did not differ from the multivari-
ate results presented in Table II. The nonparametric regression
curve and a formal test showed that the relations between coffee
consumption and renal cell cancer risk were consistent with linear
associations (p-values, test for curvature 5 0.25 for women, 0.55
for men). When coffee consumption was modeled as a continuous
variable, an increment of 237 g/day (8 oz or 237 ml) was associ-
ated with a 5% lower risk of renal cell cancer among women
(pooled multivariate RR 5 0.95; 95% CI 5 0.90–1.01), but not
among men (pooled multivariate RR 5 1.00; 95% CI 5 0.94–
1.06). The multivariable RRs obtained in the aggregated dataset
were not different from the pooled multivariable RRs (data not
shown). We could not examine the association for regular coffee
and decaffeinated coffee separately because too few studies asked
separate questions.
For tea, the pooled age-adjusted RRs were similar to the pooled
multivariate RRs (Table II). In the multivariate analyses, we found
a nonsigniﬁcant 15% lower risk of renal cell cancer among partici-
pants who consumed 1 or more 8 oz (237 ml) cups of tea per day
TABLE I – BASELINE CHARACTERISTICS OF THE COHORT STUDIES INCLUDED IN THE POOLED ANALYSES OF BEVERAGE INTAKES
AND RENAL CELL CANCER RISK
Study (Sex2) Follow-up period Baseline cohort size No. of cases3
Median intake among drinkers (g/day)
(% of nondrinkers)1
Coffee Tea Milk Juice Soda
Alpha-Tocopherol, Beta-Carotene 1985–1999 26,987 187 600 157 654 16 47
Cancer Prevention Study (M) (2) (64) (0.01) (51) (58)
Breast Cancer Detection Demonstration 1987–1999 42,007 49 – – 200 89 47
Project Follow-up Study (W) (4) (21) (61)
California Teachers Study (W) 1995–2001 100,036 35 2314 141 57 50
(14) (23) (18) (66)
Canadian National Breast Screening Study (W) 1980–2000 49,613 81 448 384 244 147 39
(15) (22) (15) (14) (43)
Cancer Prevention Study II Nutrition Cohort (W) 1992–2001 74,138 86 – – 215 78 29
(3) (19) (64)
Cancer Prevention Study II Nutrition Cohort (M) 1992–2001 66,166 220 – – 232 91 77
(3) (16) (45)
Health Professionals Follow-up Study (M) 1986–2000 47,780 116 237 102 196 159 202
(30) (42) (15) (8) (17)
Iowa Women’s Health Study (W) 1986–2000 34,588 117 597 102 245 149 104
(10) (42) (12) (9) (28)
Melbourne Collaborative Cohort Study (M) 1990–2003 14,908 50 500 500 – 79 86
(11) (19) (20) (37)
Netherlands Cohort Study (W) 1986–1993 62,573 68 500 375 180 25 29
(4) (11) (7) (41) (54)
Netherlands Cohort Study (M) 1986–1993 58,279 134 500 375 179 23 54
(3) (15) (7) (55) (47)
New York State Cohort (M) 1980–1987 30,363 62 710 237 207 158 370
(12) (64) (10) (4) (82)
Nurses’ Health Study (W) 1986–2000 68,523 86 592 102 210 152 159
(26) (37) (12) (9) (19)
Swedish Mammography Cohort (W) 1987–2004 60,604 138 443 181 345 24 23
(4) (29) (14) (37) (60)
Women’s Health Study (W) 1993–2004 38,387 49 592 102 196 111 284
(14) (33) (12) (11) (13)
Total 774,952 1,478
1For coffee and tea, an 8 oz. serving/day is equivalent to 237 g/day. For milk, an 8 oz. serving/day is equivalent to 245 g/day. For juice, a
6 oz. serving/day is equivalent to 186 g/day. For soda, a 12 oz. serving/day is equivalent to 355 g/day.–2W, Women; M, Men.–3Histologically
conﬁrmed renal cell cancer cases.–4One question on coffee and tea consumption was asked.
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compared with nondrinkers (pooled multivariate RR 5 0.85; 95%
CI 5 0.71–1.02) (Table II). The inverse association was limited to
men (pooled multivariate RR 5 0.72; 95% CI 5 0.55–0.94), and
the difference in the results between women and men was margin-
ally signiﬁcant (p value, test for between-studies heterogeneity
due to gender 5 0.09). When we additionally adjusted for multivi-
tamin use (user, nonuser) and physical activity (low, medium,
high), the results did not differ (data not shown). The multivari-
able RRs obtained in the aggregated dataset were not different
from the pooled multivariable RRs (data not shown). For both
women and men, the nonparametric regression curve and a formal
test showed that the relations between tea consumption and renal
cell cancer risk were consistent with linear associations (p-values,
test for curvature 5 0.36 for women, 0.66 for men). In the contin-
uous analyses, we found a nonsigniﬁcant 4% lower risk of renal
cell cancer for an increment of one 8 oz (237 ml) cup of tea per
day (pooled multivariate RR 5 0.96; 95% CI 5 0.89–1.03), but
the inverse association was limited to men.
No signiﬁcant associations with renal cell cancer risk were
observed for intakes of milk, soda and fruit and vegetable juice
(Table II). When we examined whole milk and reduced fat milk
separately in the 11 studies that assessed the intake of these items
separately, there were no clear associations for either type of milk
but the consumption of whole milk was uncommon in most
studies (data not shown). Neither fruit juice (13 studies) nor vege-
table juice (7 studies) was associated with risk of renal cell cancer
(data not shown). We were not able to examine artiﬁcially sweet-
ened and sugar-sweetened soda consumption separately because
only a few studies asked separate questions for these beverages.
Overall, the associations between coffee or tea intakes and renal
cell cancer risk were not signiﬁcantly modiﬁed by BMI, history of
hypertension, smoking habits (Table III), alcohol intake (non-
drinkers, drinkers; data not shown) or age at diagnosis (<68, and
 68 years old, the median age at diagnosis; data not shown).
Because there were suggestions that associations for coffee and
tea consumption varied by gender, we also examined whether the
associations for coffee and tea intake varied by hormone-related
variables. We found a marginally signiﬁcant difference by oral
contraceptive use (user, nonuser; p value, test for interaction 5
0.09) in women, but no clear differences in risk of renal cell can-
cer by parity (1 child, 2 children, 3 children), and hormone
replacement therapy use (ever, never) (p values, test for interac-
tion 0.11).
Discussion
In our pooled analysis of 13 prospective studies, we found that
neither coffee nor tea intake was associated with increased renal
cell cancer risk, but rather our results suggest that frequent coffee
or tea consumption may be associated with a modestly lower risk
of renal cell cancer. Consumption of milk, soda and fruit and veg-
etable juice was not associated with the risk of renal cell cancer.
We found suggestive differences in the apparent beneﬁts of coffee
and tea consumption on risk of renal cell cancer between women
and men which were unexpected. These gender-differences could
be due to chance but it is possible that associations between life-
style factors such as diet and renal cell cancer risk vary by hor-
mone-related variables. The incidence of renal cell cancer is more
than twice as common in men compared to women, but it remains
uncertain whether this difference in the association observed is
due to differences in endogenous estrogen levels, smoking habits
or some other factors. Caffeine metabolism has been shown to be
slower among women who received exogeneous estrogens com-
pared to women who did not54,55 partly because estrogens and
caffeine compete for the CYP1A2 isoenzyme of the P450 fam-
ily.54 Although we did not ﬁnd clear differences in the association
between coffee and tea intake and renal cell cancer risk by several
hormone-related variables, we had a limited number of cases for
these analyses.
Ecological studies have found strong positive correlations
between per capita consumption of coffee and renal cell cancer
mortality56 and incidence.57 Because coffee drinking is positively
correlated with smoking, a positive correlation between coffee
consumption and renal cell cancer risk at the ecological level
could be confounded by smoking habits. In our data, the inverse
association for coffee was stronger among never smokers com-
pared to past or current smokers, which may suggest that residual
confounding by smoking habits could obscure an inverse associa-
tion of coffee intake if the effects of smoking are not completely
controlled for. The majority of case-control studies of renal cell
cancer have found no signiﬁcant associations9–14,16,17 for coffee
consumption. Only a few prospective studies,22,24,58,59 3 of
which22,24 (2 studies were reported in 1 paper; Lee et al.22) are
included in our analysis, have examined the association between
coffee intake and risk of renal cell cancer. In the 2 cohort studies
that were not included in our analysis because they did not meet
the prespeciﬁed criteria (described in Material and Methods sec-
tion), signiﬁcant association in women and men combined58 or
non-signiﬁcant inverse association in men59 were found for coffee
consumption. Our data suggested the inverse association was lim-
ited to women, although the difference in the risk estimates
between women and men was not statistically signiﬁcant.
For tea, most, but not all16,17 case-control studies have found no
signiﬁcant association with renal cell cancer risk in men,7,12,13
women7,12,13 or both genders combined.7,9–11,14,15,18 Among 4
prospective studies22,24,25 (2 studies were reported in Lee et al.22)
that examined the association between tea consumption and renal
cell cancer risk, 322,24 were included in our analyses. The prospec-
tive study that was not included in our analyses found that black
tea consumption appeared to increase the risk of kidney cancer
death, but that green tea did not.25 However, the authors postu-
lated that, in this Japanese population, drinking black tea may be a
surrogate for a westernized diet, which may be associated with an
increased risk of renal cell cancer. In contrast, the studies in our
analysis, tea consumption was positively correlated with healthy
behaviors. Inadequate control for these healthy behaviors could
result in a spurious inverse association. However, we found little
difference between our age-adjusted results and those adjusted for
smoking habits, history of hypertension, BMI, physical activity
and multivitamin use.
Milk consumption has been associated with an increased risk of
renal cell cancer in some case-control studies9–11,20, but, as
observed in our prospective analysis, other case-control studies
have not seen an association for milk intake.17,19,21 Our ﬁnding of
no association between soda intake and renal cell cancer risk
agrees with the results from the few case-control studies that have
examined associations with either total soda intake7,11,18 or low
calorie soda intake.7 Information on intakes of milk, soda and
juice in relation to renal cell cancer risk from prospective studies
is limited.
There are several possible mechanisms by which coffee and tea
consumption might reduce the risk of renal cell cancer. First, cof-
fee and tea may improve insulin sensitivity. A possible link
between insulin sensitivity and renal cell cancer risk is suggested
by the strong positive association between obesity and renal cell
cancer risk.60 Furthermore, renal cell cancer incidence rates have
been shown to be higher in individuals with diabetes,61,62 which is
usually characterized by impaired insulin sensitivity, and in indi-
viduals with elevated fasting glucose levels.63 Coffee consumption
has been associated with improved insulin sensitivity,4 inversely
associated with the risk of diabetes,64 and inversely correlated
with C-peptide levels, a marker of insulin secretion.65 Tea con-
sumption also has been shown to improve insulin sensitivity in ex-
perimental studies,5,66 but has not been associated with risk of
Type 2 diabetes mellitus in prospective cohort studies.67,68
Second, the diluting effect caused by coffee and tea could
reduce the risk of renal cell cancer by decreasing the time that
carcinogenic solutes are in contact with renal epithelial cells.
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However, a pooled analysis of the Nurses’ Health Study and the
Health Professionals Follow-up Study, both of which were
included in our analyses, reported that total ﬂuid intake was not
associated with a lower risk of renal cell cancer.22 In this pooled
analysis, we were not able to examine if total ﬂuid intake was
associated with risk of renal cell cancer because the FFQs of 7 of
the 13 studies did not assess water consumption, an important con-
tributor to total ﬂuid intake.
Third, coffee and tea also contain phenolic compounds and bio-
active ﬂavonoids,69,70 which may reduce the risk of renal cell can-
cer by removing oxidized carcinogenic agents, reducing lipid per-
oxidation, reducing cell proliferation, or promoting apoptosis.3,71
This pooled analysis has limitations. We used only a baseline
measure of beverage intake for each study therefore we could not
investigate the effects of changes in beverage intake during
follow-up, or consumption of speciﬁc beverages during earlier age
periods or over the lifetime. Also, we only had a baseline measure
for confounding factors and potential effect modiﬁers, so that
changes in these variables during follow-up could not be taken
into consideration in our analyses. Even though our study included
a large number of cases, we could not examine the effects of high
intake of each beverage due to the small number of cases with
high intakes. Also, we could not examine regular or decaffeinated
coffee separately, types of tea, or types of soda. We were not able
to examine if the associations differed by ethnicity because over
90% of the participants in our study were Caucasian. We did not
have sufﬁcient power to examine associations separately by histo-
logical type of renal cell cancer. Smoking habits or history of
hypertension, important risk factors for renal cell cancer, were
measured in most studies, but not in all. However, in those studies
that measured smoking habits and history of hypertension, the
pooled RRs from the multivariate model presented were similar to
the pooled RRs where we did not adjust for smoking habits and
history of hypertension (data not shown).
Our analysis has several strengths. Because of the prospective
design of the studies, recall bias and selection bias do not account
for our ﬁndings. In addition, because of the large number of cases
in our study, which has not been possible in any single prospective
study, we were able to achieve better precision in our risk esti-
mates relative to the individual prospective studies. Although we
did not have information on some risk factors for renal cell cancer,
including family history of renal cell cancer, environmental expo-
sures such as asbestos, medications such as phenacetin, or
advanced kidney disease, and thus were not able to control for
these factors in our analyses, the associations that we observed are
not likely to be fully explained by these factors because these fac-
tors would need to be both common and strongly associated with
each beverage intake. Because we analyzed the primary data from
each study, we were able to model beverage intake and confound-
ing factors uniformly across studies to remove potential sources of
heterogeneity in the results across studies.
In conclusion, our results suggest that coffee and tea consumption
may be associated with a modestly lower risk of renal cell cancer,
whereas intakes of milk, juice and soda were not associated with
risk. Further studies are needed to explore possible mechanisms and
the suggestive gender-difference in risk for coffee and tea.
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